These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Comparative assay of HCG, HCT and HCS in molar pregnancy. Tojo S; Mochizuki M; Kanazawa S Acta Obstet Gynecol Scand; 1974; 53(4):369-73. PubMed ID: 4474790 [TBL] [Abstract][Full Text] [Related]
23. Twenty-three year old caucasian female at 23 weeks gestation with vaginal bleeding and abnormal ultrasound study. Pederson KA; Luechtefeld NW; Barlow JF S D J Med; 1983 Dec; 36(12):5-10. PubMed ID: 6583843 [No Abstract] [Full Text] [Related]
24. The ultrasound diagnosis of hydatidiform mole and coexistent fetus associated with elevated maternal serum alpha feto protein. Lamb GH; Oakley R Br J Radiol; 1981 Mar; 54(639):268. PubMed ID: 6162502 [No Abstract] [Full Text] [Related]
25. Serum human chorionic somatomammotropin in unaborted hydatidiform mole. Dawood MY; Teoh ES Obstet Gynecol; 1976 Feb; 47(2):183-8. PubMed ID: 1250540 [TBL] [Abstract][Full Text] [Related]
26. Study on the systematic use of serial estimation of human placental lactogen (hPL) and human chorionic gonadotropin (hCG) for the management of trophoblastic neoplasia. Chough SY Endocrinol Jpn; 1973 Feb; 20(1):9-21. PubMed ID: 4353253 [No Abstract] [Full Text] [Related]
27. [Changes in serum human chorionic gonadotropin in patients with hydatidiform mole following evacuation]. Wang X Zhonghua Fu Chan Ke Za Zhi; 1988 Nov; 23(6):362-4, 388. PubMed ID: 2854773 [No Abstract] [Full Text] [Related]
28. [Gestational trophoblastic disease: limits of anatamo-clinical diagnosis in Africa]. N'Golet A; Moukassa D Med Trop (Mars); 2000; 60(1):101-2. PubMed ID: 10989800 [No Abstract] [Full Text] [Related]
29. Strict clinicopathologic criteria in the diagnosis of partial hydatidiform mole: a plea renewed. Szulman AE; Surti U Am J Obstet Gynecol; 1985 Aug; 152(8):1107-8. PubMed ID: 3895965 [No Abstract] [Full Text] [Related]
30. Value of HCG and HCS measurement in clinical practice. Crosignani PG; Trojsi L; Attanasio AE; Finzi GC Obstet Gynecol; 1974 Nov; 44(5):673-81. PubMed ID: 4213790 [No Abstract] [Full Text] [Related]
31. Radioimmunoassay of the beta-subunit of human chorionic gonadotropin, monitor of chemotherapy in gestational trophoblastic neoplasm. Jones WB; Lehr M; Lewis JL Surg Forum; 1973; 24():563-5. PubMed ID: 4377042 [No Abstract] [Full Text] [Related]
33. Negative pregnancy test: could it be a molar pregnancy? Ofinran O; Papaioannou S; Kandavel V; Shrivastava S; Hall S; Tzafettas J J Obstet Gynaecol; 2007 Nov; 27(8):857-8. PubMed ID: 18097917 [No Abstract] [Full Text] [Related]
34. [Hysteroscopy in the diagnosis and treatment of residua after evacuation of hydatidiform mole]. Wilczak M; Sajdak S; Woźniak J; Cwojdziński M; Nowak-Markwitz E; Pisarski T Ginekol Pol; 1994 Sep; 65(9):522-6. PubMed ID: 7536698 [TBL] [Abstract][Full Text] [Related]
35. Plasma human chorionic gonadotropin disappearance in hydatidiform mole: a central registry report from the Netherlands. Franke HR; Risse EK; Kenemans P; Houx PC; Stolk JG; Vooijs GP Obstet Gynecol; 1983 Oct; 62(4):467-73. PubMed ID: 6888825 [TBL] [Abstract][Full Text] [Related]
36. Maternal serum biochemical screening for pregnancy complications other than aneuploidy. Pahal GS; Jauniaux E Curr Opin Obstet Gynecol; 1997 Dec; 9(6):379-86. PubMed ID: 9425582 [TBL] [Abstract][Full Text] [Related]
37. Serum placental lactogen levels in patients with molar pregnancy and trophoblastic tumors. Saxena B; Goldstein DP; Emerson K; Selenkow HA Am J Obstet Gynecol; 1968 Sep; 102(1):115-21. PubMed ID: 4299677 [No Abstract] [Full Text] [Related]